NASDAQ: PMVP
Pmv Pharmaceuticals Inc Stock Ownership - Who owns Pmv Pharmaceuticals?

Insider buying vs selling

Have Pmv Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Henry MacKPresident and CEO2025-10-27220,643$1.37
$302.28kBuy
Orbimed Advisors LLC10% Owner2025-10-231,000,000$1.52
$1.52MSell
Orbimed Advisors LLC10% Owner2025-09-10500,000$1.80
$900.00kSell

1 of 1

PMVP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMVP insiders and whales buy or sell their stock.

PMVP Shareholders

What type of owners hold Pmv Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Arnold L. Oronsky12.13%6,469,911$7.89MInsider
Bml Capital Management LLC9.98%5,320,000$6.49MInstitution
Orbimed Advisors LLC9.54%5,089,330$6.21MInsider
Interwest Partners X LP8.44%4,502,480$5.49MInsider
Tang Capital Management LLC7.96%4,245,085$5.18MInstitution
Sio Capital Management LLC5.77%3,076,580$3.75MInstitution
Arrowmark Colorado Holdings LLC5.39%2,872,764$3.50MInstitution
Euclidean Capital LLC4.93%2,627,643$3.21MInstitution
V. Oncology Scs Sicavsif Nextech4.74%2,528,290$3.08MInsider
Eversept Partners LP4.40%2,348,360$2.86MInstitution

1 of 3

PMVP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMVP58.61%41.39%Net Selling
IMA33.70%66.30%Net Buying
DOMH7.11%68.39%Net Selling
EDSA21.11%78.89%Net BuyingNet Buying
ANVS13.63%15.18%Net BuyingNet Buying

Pmv Pharmaceuticals Stock Ownership FAQ

Who owns Pmv Pharmaceuticals?

Pmv Pharmaceuticals (NASDAQ: PMVP) is owned by 69.31% institutional shareholders, 48.94% Pmv Pharmaceuticals insiders, and 0.00% retail investors. Arnold L. Oronsky is the largest individual Pmv Pharmaceuticals shareholder, owning 6.47M shares representing 12.13% of the company. Arnold L. Oronsky's Pmv Pharmaceuticals shares are currently valued at $7.89M.

If you're new to stock investing, here's how to buy Pmv Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.